BioCentury | Oct 29, 2012
Company News

Celogos, Clean Cells, Laboratoire francais gene/cell therapy news

...$39.1 million) from France's OSEO agency. The facility is expected to begin operations in 4Q13. Celogos S.A....
...project is developing the first five products to be manufactured: CEL-02, a cell therapy from Celogos...
BioCentury | Feb 19, 2007
Company News

Celogos, Stem Cell Sciences KK deal

...treat stress urinary incontinence using Celogos’ rational cell design (RCD) technology for myoblast cell implantation. Celogos’...
...Tokyo, Japan) and Stem Cell Sciences plc (LSE:STEM, Edinburgh, U.K.). Further details were not disclosed. Celogos S.A....
BioCentury | May 15, 2006
Product Development

Regenerating muscle

...a common problem for people who undergo certain types of surgery or go through childbirth. Celogos...
...in the U.S., the EU and Japan. Estimates are less clear for anal incontinence, but Celogos...
...host myofibers and contribute to muscle repair, said André Ulmann, chairman and CEO of Celogos. Celogos...
BioCentury | Sep 10, 2001
Company News

Celogos SA, Pasteur Institute gene/cell therapy news

...Celogos was launched by Biotop, the business incubator of the Pasteur Institute. Celogos will focus on...
...Rational Cell Design, combines bioinformatics with cellular technology in efforts to assess cell culture quality. Celogos...
BioCentury | Sep 10, 2001
Company News

Celogos SA board of directors update

Celogos SA , Paris, France Business: Gene/Cell therapy Appointed: Christian Pinset, research director at CNRS and co-manager of the cellular development laboratory at the Pasteur Institute WIR Staff...
BioCentury | Sep 5, 2001
Company News

Pasteur Institute launches Celogos

...Celogos (Paris, France) has been launched by Biotop, the business incubator of the Pasteur Institute. Celogos...
Items per page:
1 - 6 of 6
BioCentury | Oct 29, 2012
Company News

Celogos, Clean Cells, Laboratoire francais gene/cell therapy news

...$39.1 million) from France's OSEO agency. The facility is expected to begin operations in 4Q13. Celogos S.A....
...project is developing the first five products to be manufactured: CEL-02, a cell therapy from Celogos...
BioCentury | Feb 19, 2007
Company News

Celogos, Stem Cell Sciences KK deal

...treat stress urinary incontinence using Celogos’ rational cell design (RCD) technology for myoblast cell implantation. Celogos’...
...Tokyo, Japan) and Stem Cell Sciences plc (LSE:STEM, Edinburgh, U.K.). Further details were not disclosed. Celogos S.A....
BioCentury | May 15, 2006
Product Development

Regenerating muscle

...a common problem for people who undergo certain types of surgery or go through childbirth. Celogos...
...in the U.S., the EU and Japan. Estimates are less clear for anal incontinence, but Celogos...
...host myofibers and contribute to muscle repair, said André Ulmann, chairman and CEO of Celogos. Celogos...
BioCentury | Sep 10, 2001
Company News

Celogos SA, Pasteur Institute gene/cell therapy news

...Celogos was launched by Biotop, the business incubator of the Pasteur Institute. Celogos will focus on...
...Rational Cell Design, combines bioinformatics with cellular technology in efforts to assess cell culture quality. Celogos...
BioCentury | Sep 10, 2001
Company News

Celogos SA board of directors update

Celogos SA , Paris, France Business: Gene/Cell therapy Appointed: Christian Pinset, research director at CNRS and co-manager of the cellular development laboratory at the Pasteur Institute WIR Staff...
BioCentury | Sep 5, 2001
Company News

Pasteur Institute launches Celogos

...Celogos (Paris, France) has been launched by Biotop, the business incubator of the Pasteur Institute. Celogos...
Items per page:
1 - 6 of 6